Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL865736 | 0.78 | LMNA (0.48) | MEN1KMT2A | |
| SCHEMBL2976462 | 0.75 | TET2 (0.42) | CA1CA2MEN1KMT2ATET2 | |
| SCHEMBL865735 | 0.73 | CA1 (0.35) | CA1CA2MEN1KMT2A | |
| SCHEMBL8419645 | 0.71 | ALDH1A1 (0.42) | CA1CA2MEN1KMT2A | |
| SCHEMBL5077836 | 0.71 | CA1 (0.37) | CA1CA2 | |
| SCHEMBL850125 | 0.70 | TSHR (0.55) | MEN1KMT2A | |
| SCHEMBL5247491 | 0.70 | TSHR (0.55) | MEN1KMT2A | |
| SCHEMBL848884 | 0.70 | TSHR (0.55) | MEN1KMT2A | |
| SCHEMBL5247186 | 0.70 | TSHR (0.55) | MEN1KMT2A | |
| SCHEMBL3319531 | 0.69 | TET2 (0.41) | CA1CA2MEN1KMT2ATET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0986574-B1 | 11BETA-ARYL SUBSTITUTED 14,17-ETHANO-OESTRATRIENS, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS. | SCHERING AG (DE) | 2002-04-03 | — | — | EP | disclosed |
| EP-0906332-B1 | 7ALPHA-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7ALPHA-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS | SCHERING AG (DE) | 2001-11-28 | — | — | EP | disclosed |
| US-6288051-B1 | ESTROGEN-DEPENDENT BREAST CANCER TREATMENT | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-09-11 | — | — | US | disclosed |
| US-6229029-B1 | SELECTIVE ESTROGENS EFFECTING BONE, THE CARDIOVASCULAR SYSTEM AND THE CENTRAL NERVOUS SYSTEM; HORMONE REPLACEMENT THERAPY; OSTEOPOROSIS; NO ACTIVITY IN THE UTERUS AND LIVER | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-05-08 | — | — | US | disclosed |
| EP-0986574-A1 | 11$g(b)-ARYL SUBSTITUTED 14,17-ETHANO-OESTRATRIENS, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS. | Schering Aktiengesellschaft (DE) | 2000-03-22 | — | — | EP | disclosed |
| WO-1998055499-A1 | 11β-ARYL SUBSTITUTED 14,17-ETHANO-OESTRATRIENS, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS. | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-12-10 | — | — | WO | disclosed |
| EP-0642529-B1 | 11BETA-SUBSTITUTED 14,17-ETHANOESTRATRIENES, PROCESS FOR PREPARING THESE COMPOUNDS AND THEIR USE FOR PREPARING MEDICAMENTS | SCHERING AG (DE) | 1996-12-11 | — | — | EP | disclosed |
| US-5502046-A | 11β-substituted 14,17-ethanoestratrienes, process for their production and their use as pharmaceutical agents | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-03-26 | — | — | US | disclosed |
| EP-0642529-A1 | 11-g(b)-SUBSTITUTED 14,17-ETHANOESTRATRIENES, PROCESS FOR PREPARING THESE COMPOUNDS AND THEIR USE FOR PREPARING MEDICAMENTS. | SCHERING AG (DE) | 1995-03-15 | — | — | EP | disclosed |
| EP-0546591-A2 | 11-beta-substituted 14,17-ethanoestratrienes, process for their production and their use in the preparation of medicines | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-06-16 | — | — | EP | disclosed |
| WO-1993006124-A1 | 11β-SUBSTITUTED 14,17-ETHANOESTRATRIENES, PROCESS FOR PREPARING THESE COMPOUNDS AND THEIR USE FOR PREPARING MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-04-01 | — | — | WO | disclosed |